Back
Reviva Pharmaceuticals Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
59
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
1.27
Seasonality Move:
-4.88%
Sell
43
NBY
NovaBay Pharmaceuticals
Last Price:
0.72
Seasonality Move:
-18.64%
Buy
59
Reviva Pharmaceuticals Holdings (RVPH)
is a Buy
Is Reviva Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.28. The Score for RVPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- RVPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.74. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVPH Stock Price Chart
What is Reviva Pharmaceuticals Holdings's stock price today?
-
The Reviva Pharmaceuticals Holdings share price today is $1.28
The current trend is moderately bullish and RVPH is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.74
The current trend is relatively stagnant and NBY is experiencing slight selling pressure.
RVPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 56.07 | Buy |
Chaikin Money Flow: | -41729 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.94 - 1.32) | Buy |
Bollinger Bands (100): | (0.83 - 1.89) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 61.79 | Buy |
Chaikin Money Flow: | -53331864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.45 - 0.57) | Buy |
Bollinger Bands (100): | (0.56 - 3.36) | Sell |
RVPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Buy |
20-day SMA: | 1.2 | Buy |
50-day SMA: | 1.07 | Buy |
200-day SMA: | 2.61 | Sell |
8-day EMA: | 1.27 | Buy |
20-day EMA: | 1.2 | Buy |
50-day EMA: | 1.2 | Buy |
200-day EMA: | 2.31 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.52 | Buy |
20-day SMA: | 0.5 | Buy |
50-day SMA: | 0.83 | Sell |
200-day SMA: | 3.74 | Sell |
8-day EMA: | 0.55 | Buy |
20-day EMA: | 0.55 | Buy |
50-day EMA: | 0.94 | Sell |
200-day EMA: | 8.27 | Sell |
Reviva Pharmaceuticals Holdings Earnings Growth & RVPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.71 per share, and a decrease next year of $0.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Reviva Pharmaceuticals Holdings Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |